These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 38339240)
1. In Vitro Sensitivity of Neuroendocrine Neoplasms to an Armed Oncolytic Measles Vaccine Virus. Scheicher NV; Berchtold S; Beil J; Smirnow I; Schenk A; Lauer UM Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339240 [TBL] [Abstract][Full Text] [Related]
2. Pulsed versus continuous application of the prodrug 5-fluorocytosine to enhance the oncolytic effectiveness of a measles vaccine virus armed with a suicide gene. Yurttas C; Berchtold S; Malek NP; Bitzer M; Lauer UM Hum Gene Ther Clin Dev; 2014 Jun; 25(2):85-96. PubMed ID: 24933569 [TBL] [Abstract][Full Text] [Related]
3. A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma. Lange S; Lampe J; Bossow S; Zimmermann M; Neubert W; Bitzer M; Lauer UM Hum Gene Ther; 2013 May; 24(5):554-64. PubMed ID: 23550539 [TBL] [Abstract][Full Text] [Related]
4. Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase. Hartkopf AD; Bossow S; Lampe J; Zimmermann M; Taran FA; Wallwiener D; Fehm T; Bitzer M; Lauer UM Gynecol Oncol; 2013 Aug; 130(2):362-8. PubMed ID: 23676551 [TBL] [Abstract][Full Text] [Related]
5. An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis. Lampe J; Bossow S; Weiland T; Smirnow I; Lehmann R; Neubert W; Bitzer M; Lauer UM Gene Ther; 2013 Nov; 20(11):1033-41. PubMed ID: 23719065 [TBL] [Abstract][Full Text] [Related]
6. Primary resistance phenomena to oncolytic measles vaccine viruses. Noll M; Berchtold S; Lampe J; Malek NP; Bitzer M; Lauer UM Int J Oncol; 2013 Jul; 43(1):103-12. PubMed ID: 23612727 [TBL] [Abstract][Full Text] [Related]
7. Assessing and Overcoming Resistance Phenomena against a Genetically Modified Vaccinia Virus in Selected Cancer Cell Lines. Berchtold S; Beil J; Raff C; Smirnow I; Schell M; D'Alvise J; Gross S; Lauer UM Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076270 [TBL] [Abstract][Full Text] [Related]
8. A Three-Dimensional Organoid Model of Primary Breast Cancer to Investigate the Effects of Oncolytic Virotherapy. Carter ME; Hartkopf AD; Wagner A; Volmer LL; Brucker SY; Berchtold S; Lauer UM; Koch A Front Mol Biosci; 2022; 9():826302. PubMed ID: 35223990 [No Abstract] [Full Text] [Related]
14. Chemovirotherapy for pancreatic cancer: Gemcitabine plus oncolytic measles vaccine virus. May V; Berchtold S; Berger A; Venturelli S; Burkard M; Leischner C; Malek NP; Lauer UM Oncol Lett; 2019 Nov; 18(5):5534-5542. PubMed ID: 31612061 [TBL] [Abstract][Full Text] [Related]
15. Chemovirotherapy of malignant melanoma with a targeted and armed oncolytic measles virus. Kaufmann JK; Bossow S; Grossardt C; Sawall S; Kupsch J; Erbs P; Hassel JC; von Kalle C; Enk AH; Nettelbeck DM; Ungerechts G J Invest Dermatol; 2013 Apr; 133(4):1034-42. PubMed ID: 23223133 [TBL] [Abstract][Full Text] [Related]
16. The Oncolytic Herpes Simplex Virus Talimogene Laherparepvec Shows Promising Efficacy in Neuroendocrine Cancer Cell Lines. Kloker LD; Berchtold S; Smirnow I; Schaller M; Fehrenbacher B; Krieg A; Sipos B; Lauer UM Neuroendocrinology; 2019; 109(4):346-361. PubMed ID: 31280274 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer. Singh HM; Leber MF; Bossow S; Engeland CE; Dessila J; Grossardt C; Zaoui K; Bell JC; Jäger D; von Kalle C; Ungerechts G Mol Ther Oncolytics; 2021 Jun; 21():340-355. PubMed ID: 34141871 [TBL] [Abstract][Full Text] [Related]
18. Human precision-cut liver tumor slices as a tumor patient-individual predictive test system for oncolytic measles vaccine viruses. Zimmermann M; Armeanu S; Smirnow I; Kupka S; Wagner S; Wehrmann M; Rots MG; Groothuis GM; Weiss TS; Königsrainer A; Gregor M; Bitzer M; Lauer UM Int J Oncol; 2009 May; 34(5):1247-56. PubMed ID: 19360338 [TBL] [Abstract][Full Text] [Related]